Alain Mucchielli

Summary

Alain Mucchielli (born 3 October 1947 in Toulon) is a French biochemist and public health physician.

Alain Mucchielli
Born (1947-10-03) 3 October 1947 (age 76)
Toulon (France)
Citizenship France
Alma materLille (France), Nice
AwardsRolleston Award
Scientific career
FieldsBiochemistry, Public Health
InstitutionsCEA, INSERM
Theses
  • PhD: Evaluation toxicologique des produits formés au cours de l'irradiation gamma (cobalt 60) de l'amidon : influence sur la croissance et le métabolisme bactériens  (1975)
  • MD: Dynamics of antibody transfer from mother to fetus through the yolk-sac cells in the rat (1981)

Biography edit

In 1975 Mucchielli obtained a PhD with a thesis on food irradiation at the Lille Institut Pasteur in collaboration with the CEA Cadarache Research Centre. After joining the Institut National de la Santé et de la Recherche Médicale in 1977, his work focused on alpha-fetoprotein in Nice, France, and the trophoblast antigens in the Blond McIndoe Centre for Transplantation Biology, Queen Victoria Hospital, East Grinstead, England.[1] In 1981, he obtained an MD with a thesis on antibody transfer from mother to fetus in the University of Nice.

In 1984, he engaged in street work. In 1987, along with seven other doctors, he co-founded a Red Cross Volunteer Centre for homeless people.[2] Difficulties faced by people in this center committed him in harm reduction, and he organized in the early 1990s a medical care network for intravenous drug users.[3][4]

This network supported about 500 drug users in the south of France from 1990 to 1997, and, since 1993, it provided substitution treatment for drug users suffering very difficult conditions.[5][6]

In 1997, in Paris, he was "awarded the National Rolleston Award … for his advocacy of harm reduction in the face of opposition and doubt and for his efforts to bring about changes in Nice, a city badly affected by the problems arising from drug use and HIV".[7][8] On 27 June 1998, he participated in the creation of the French Association for the Reduction of Drug-Related Harm, which brought together members who were involved in the majority of projects and actions in the field of harm reduction.[9][10] Its initial ambition was to bring together, beyond the actors who were already involved, all those who were professionally concerned by the issue of drug use (police, justice, health, social, education, sport, culture, leisure) but also ordinary citizens, as well as their representatives.[11]

After obtaining a speciality in Public Health, he was recruited in 1998 as Director of the Public Health Unit of the Mutualité Française des Alpes-Maritimes (which includes the SAMU Social in Nice[12]). He then took on a regional management role in the Mutualité Française Provence-Alpes-Côte d'Azur.[13]

References edit

  1. ^ Faulk, W. P.; Hsi, B. L.; McIntyre, J. A.; Yeh, C. J.; Mucchielli, A. (1982). "Antigens of human extra-embryonic membranes". Journal of Reproduction and Fertility. Supplement. 31: 181–199. ISSN 0449-3087. PMID 6762431.
  2. ^ (in French) Présence Croix-Rouge : Vie et bonté
  3. ^ (in French) G. Decrouy et al., « L’exclusion sociale dans les Alpes-Maritimes, V.I.H., drogue, délinquance, précarité : enquêtes sur le terrain », Paris, Éditions L'Harmattan, 1997, 312 p.
  4. ^ "L'héroïne, la cocaïne et le crack en France - Chapitre 2". www.cedro-uva.org. Retrieved 2022-01-08.
  5. ^ Gauthier (J.F.); Chabalier (H.); Manoukian (P.) (1994). Ruban rouge (17) : Toxicomanie et réduction des risques. Retrieved 2022-01-08.
  6. ^ French Monitoring Centre for Drugs and Drug Addiction
  7. ^ "Harm Reduction Awards". www.hri.global. Harm Reduction International. Retrieved 3 June 2022.
  8. ^ 1997 National Rolleston Award
  9. ^ Vignau, Jean; Boissonnas, Alain; Tignol, Jean; Millot, Yannick; Mucchielli, Alain (2003). "[French nationwide survey of abstinence-oriented treatments in opiate-addicted patients. Results at 12 months]". Annales de Médecine Interne. 154 Spec No 2: S23–32. ISSN 0003-410X. PMID 14760224.
  10. ^ Lavignasse, Pierre; Lowenstein, William; Batel, Philippe; Constant, Marie-Véronique; Jourdain, Jean-Jacques; Kopp, Pierre; Reynaud-Maurupt, Catherine; Riff, Bertrand; Videau, Benjamin; Mucchielli, Alain (2002). "Economic and social effects of high-dose buprenorphine substitution therapy. Six-month results". Annales de Médecine Interne. 153 (3 Suppl): 1S20–26. ISSN 0003-410X. PMID 12218879.
  11. ^ "l'A.F.R., 10 ans déjà" (in French). Retrieved 2022-02-12.
  12. ^ Trajectoires de la précarité professionnelle et sociale en région PACA, Colloque DROS PACA 2006
  13. ^ Lancestre, Maxime (2016-01-23). "Feu vert à la création d'une Maison de santé". LaProvence (in French). S.A. La Provence. Retrieved 2022-02-18.

Sources edit

  • L'héroïne, la cocaïne et le crack en France